1. Home
  2. RMNI vs CMPX Comparison

RMNI vs CMPX Comparison

Compare RMNI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$4.16

Market Cap

385.0M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.09

Market Cap

371.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMNI
CMPX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
385.0M
371.0M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
RMNI
CMPX
Price
$4.16
$2.09
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$5.00
$14.57
AVG Volume (30 Days)
388.5K
3.8M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
197.50
N/A
EPS
0.01
N/A
Revenue
$431,496,000.00
N/A
Revenue This Year
$6.02
N/A
Revenue Next Year
$5.50
$934.41
P/E Ratio
$415.50
N/A
Revenue Growth
5.33
N/A
52 Week Low
$2.87
$1.61
52 Week High
$5.38
$6.88

Technical Indicators

Market Signals
Indicator
RMNI
CMPX
Relative Strength Index (RSI) 60.55 40.68
Support Level $3.36 $1.88
Resistance Level $4.34 $2.47
Average True Range (ATR) 0.15 0.11
MACD -0.01 0.06
Stochastic Oscillator 59.59 31.82

Price Performance

Historical Comparison
RMNI
CMPX

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: